ABPA

9 registered clinical trials studyying ABPA — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients W NCT07362667	Qianfoshan Hospital	—
Recruiting	Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis NCT07530770	Qianfoshan Hospital	—
Recruiting	Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and Bronchiectasis NCT07313904	First Affiliated Hospital of Ningbo University	—
Recruiting	A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA NCT07362693	Qianfoshan Hospital	—
Withdrawn	Allergic Bronchopulmonary Aspergillosis Prescreening Study NCT05903612	Community Pharmacology Services Ltd	—
Terminated	Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA NCT05667662	Pulmatrix Inc.	Phase 2
Withdrawn	Benralizumab in the Treatment of Patients With Severe Asthma With ABPA NCT04108962	Baylor Research Institute	Phase 4
Unknown	Cytokine Profile of Allergic Bronchopulmonary Aspergillosis NCT03643185	Shanghai Pulmonary Hospital, Shanghai, China	—
Completed	Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis NCT02853175	Hôpital Haut Lévêque	—